[
    [
        {
            "time": "2021-11-09",
            "original_text": "人福医药：两项药品纳入国家医保目录",
            "features": {
                "keywords": [
                    "人福医药",
                    "药品",
                    "纳入",
                    "国家医保目录"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-11-09",
            "original_text": "人福医药：公司产品注射用苯磺酸瑞马唑仑、咪达唑仑口服溶液纳入国家医保目录",
            "features": {
                "keywords": [
                    "人福医药",
                    "注射用苯磺酸瑞马唑仑",
                    "咪达唑仑口服溶液",
                    "纳入",
                    "国家医保目录"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-11-09",
            "original_text": "2021国谈“复战”品种结果直击！哌柏西利、O药、K药“三谈无缘”；GV-971、瑞马唑仑、达雷妥尤单抗…“复战入围”",
            "features": {
                "keywords": [
                    "国谈",
                    "复战",
                    "哌柏西利",
                    "O药",
                    "K药",
                    "GV-971",
                    "瑞马唑仑",
                    "达雷妥尤单抗"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]